# Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study

> **NCT03600766** · PHASE2 · UNKNOWN · sponsor: **Mansoura University** · enrollment: 50 (estimated)

## Conditions studied

- BPH
- Erectile Dysfunction
- Prostate Hyperplasia
- Erectile Abnormalities
- Prostatic Neoplasms

## Interventions

- **DRUG:** Mirabegron
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03600766
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03600766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03600766, "Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03600766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*